GC Biotherapeutics Overview

  • Founded
  • 2014
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 3

GC Biotherapeutics General Information

Description

Operator of a biopharmaceutical company in South Korea. TheThe company manufactures and distributes intravenous immunoglobulin (IVIG) and albumin products for the treatment of patients with infectious, immune diseases and burns.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Pharmaceuticals
Acquirer
Primary Office
  • 2911 Marie-Curie Avenue
  • Montreal, Quebec H4S 0B7
  • Canada
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

GC Biotherapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore GC Biotherapeutics‘s full profile, request access.

Request a free trial

GC Biotherapeutics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore GC Biotherapeutics‘s full profile, request access.

Request a free trial